IL-4, IL-17 and CD163 Immunoexpression and IL-6 Gene Polymorphism in Chronic Hepatitis C Patients and Associated Hepatocellular Carcinoma

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Aboushousha T.; Emad M.; Rizk G.; Ragab K.; Hammam O.; Fouad R.; Helal N.S.

Journal: Asian Pacific Journal of Cancer Prevention

Publisher: Asian Pacific Organization for Cancer Prevention

Publication Date: 1 April 2021

Volume / Issue: Volume 22 / Issue 4

Pages: 1105–1113

ISSN: 15137368

DOI: 10.31557/APJCP.2021.22.4.1105

Scopus: View on Scopus

PubMed: 33906302

Document Type: Article

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Aboushousha T., Department oF Pathology, Theodor Bilharz Research Institute, Giza, Egypt; Emad M., Faculty of Biotechnology, October University for Modern Sciences and Arts, Giza, Egypt; Rizk G., Faculty of Biotechnology, October University for Modern Sciences and Arts, Giza, Egypt; Ragab K., Department of Hepatology and Gastroenterology, Theodor Bilharz Research Institute, Giza, Egypt; Hammam O., Department oF Pathology, Theodor Bilharz Research Institute, Giza, Egypt; Fouad R., Department of Hematology, Theodor Bilharz Research Institute, Giza, Egypt; Helal N.S., Department oF Pathology, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

Objective: To assess the expression of IL-4, IL-17 and CD-163 as well as study of IL6-572 C/G gene polymorphism in chronic HCV and HCC on top of HCV. Methods: Sixty HCC specimens and 60 adjacent hepatic tissue with HCV of different grades of necro-inflammation and different stages of fibrosis. In addition to 55 HCV, 60 HCC and 50 healthy venous blood samples for evaluation of IL6-572 C/G gene polymorphism. Results: high expression of IL-4, IL-17 and CD163 in higher grades of activity, late stages of fibrosis and higher degrees of steatosis of HCV. IL-4 and CD163 showed higher expression in advanced grades of HCC, while IL-17 more expressed in lower grades. No significant difference in IL6-572 C/G gene polymorphism among studied groups regarding G/C, G/G, C/C frequencies or G and C allele’s frequencies. Conclusion: IL-4, IL-17 and CD163 were associated with HCV severity. Their expression in HCC suggests their important role in HCC development. Blocking of these proteins may be a good target to control inflammation in HCV and can hinder progression to cirrhosis then to HCC. On the other hand, IL6-572 promoter gene polymorphism is neither associated with HCV infection nor with HCC development and its progression. © 2021. All Rights Reserved.


Keywords

CD136; HCC; HCV; IL-17; IL-4; IL-6; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chronic; Humans; Interleukin-17; Interleukin-4; Interleukin-6; Liver Neoplasms; Receptors, Cell Surface; CD163 antigen; cell surface receptor; differentiation antigen; interleukin 17; interleukin 4; interleukin 6; leukocyte antigen; tumor marker; chronic hepatitis C; genetic predisposition; genetics; human; liver cell carcinoma; liver tumor; metabolism


Citation Information

Scopus Citations: 10


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer